Arcadia Biosciences, Inc. last reported quarterly results on Aug 13, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $1.4 million (-0.8% year over year) and diluted EPS of -$2.09. It usually reports 38–45 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 6, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Friday. Based on last year's release for the same quarter on Nov 7, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 38–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 13, 2026
44 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
1
-0.8%
|
-6
-40.6%
|
-2.09
+35.9%
|
|
May 14, 2026
44 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1
-8.3%
|
-4
-268.7%
|
-2.11
-211.1%
|
|
Nov 7, 2025
38 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1
-15.3%
|
1
+153.1%
|
0.62
+152.5%
|
|
Aug 14, 2025
45 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
1
+11.4%
|
-4
-520.2%
|
-3.26
-517.9%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
1
+21.6%
|
3
+207.3%
|
1.90
+206.7%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
2
+18.4%
|
-2
+37.2%
|
-1.18
+37.6%
|
|
Aug 13, 2024
44 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
May 9, 2024
39 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Crude Petroleum & Natural Gas (SIC 1311)
- Listed as
- RKDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1469443
Other Crude Petroleum & Natural Gas companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.